Yes, Nasopharyngitis is the most common side effect of tofacitinib, seen in around 15-20 percent of patients and they gradually disappear with continuous use.
Consult ur Rheumatologist for further details
Answered2022-05-12 11:15:13
Let others know if this answer was helpful